Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Andrew Thomas takes up UK comms agency role

Joins London-based Red Door Communications as head of international

Red Door Communications Pfizer Andrew ThomasPfizer's Andrew Thomas has moved agency-side to take up the role of head of international at London-based healthcare agency Red Door Communications.

Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada.

During this time, he handled a portfolio that included many of the company's highest profile medicines and led campaigns that were later recognised and celebrated at PMEA and Communiqué Awards.

“My time at Pfizer,” Thomas said, “required me to work across complex organisational structures and to understand what works, what doesn't and, most importantly, why that was the case.

“Success in that role was ultimately predicated on an ability to build, maintain and cultivate effective relationships based on trust and shared ownership with internal and external stakeholders alike.

“I believe those skills mean I will be able to make a real contribution to the Red Door Communications team and help develop their existing international offering still further”.

Thomas spent six years at Pfizer and prior to serving at the pharma company he worked at comms agencies Lowe Fusion and then Cohn and Wolfe.

Commenting on the appointment, Catherine Warne, head of Creston Health Group, said: “I have known Andrew for many years as a competitor and then a client. He is great fun, hugely well liked and respected in our industry and a proven influencer at a senior level.

“We are very excited that he is joining us and believe he is the ideal person to drive our international business."

7th September 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

From insightful consultancy to flawless campaign execution, we apply our unrivalled blend of exceptional quality, experience, innovation and multi-channel award-winning...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...